
NextGen Healthcare Cash Flow 2023-2008 | NXGN
Brief cash flow overview of NextGen Healthcare
Cash flow changes are traced through the five latest available reports from 2019 to 2023.
Cash from operations fell 13.5%, from $50.5 million to $43.7 million. The direction warrants attention.
Each of the five years produced positive cash from operations, indicating stable cash generation.
Operating cash margin was stable at 9.5% initially and 6.7% at the end.
Conclusion
NextGen Healthcare's cash generation remains workable and supports the business, though some uses of cash limit flexibility.
Annual Cash Flow NextGen Healthcare
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
43.7 M | 53.5 M | 98.5 M | 85.6 M | 50.5 M | 74 M | 110 M | 40.8 M | 82.8 M | 104 M | 68.1 M | 78.1 M | 70.3 M | 55.2 M | 48.7 M | - |
Depreciation & Amortization |
5.09 M | 6.9 M | 8 M | 8.17 M | 10.3 M | 10.5 M | 10.1 M | 8.83 M | 9.32 M | 8.07 M | 6.93 M | 5.2 M | 4.3 M | 3.66 M | 2.91 M | - |
Accounts Payables |
12 M | 9.12 M | 11.4 M | 10.5 M | 5.43 M | 4.21 M | 4.62 M | 11.1 M | 10 M | 7.89 M | 11.5 M | 4.53 M | 6.69 M | 3.34 M | - | - |
Accounts Receivables |
88.5 M | 76.1 M | 77.5 M | 80 M | 87.5 M | 85 M | 83.4 M | 94 M | 108 M | 113 M | 148 M | 146 M | 140 M | 107 M | - | - |
Total Inventories |
- | - | - | - | 120 K | 180 K | 158 K | 555 K | 622 K | 834 K | 710 K | 1.24 M | 1.93 M | 1.34 M | - | - |
All numbers in USD currency
Quarterly Cash Flow NextGen Healthcare
| 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-17.5 M | -8.1 M | 36 M | 33.8 M | -4.64 M | - | 36.6 M | 20.5 M | 313 K | - | 76 M | 48 M | - | - | 64.4 M | 40.8 M | 17.7 M | - | 33.3 M | 14.9 M | 17 M | - | 33.3 M | 14.9 M | 3.01 M | - | 56.8 M | 38.1 M | 12.8 M | - | 81.4 M | 56.4 M | 12.9 M | - | 27.3 M | 13.9 M | 3.71 M | - | 58.7 M | 42.7 M | 18.6 M | - | 70.5 M | 42.8 M | 31.5 M | - | 44.8 M | 28.7 M | 19.8 M | - | 61.7 M | 37.1 M | 21.5 M | 60.3 M | 36.7 M | 19.4 M |
Depreciation & Amortization |
2.06 M | 1.12 M | 3.84 M | 2.65 M | 1.29 M | - | 5.41 M | 3.78 M | 2.11 M | - | 6.09 M | 3.94 M | - | - | 6.45 M | 4.1 M | 2 M | - | 7.72 M | 5 M | 2.09 M | - | 7.72 M | 5 M | 2.39 M | - | 8.02 M | 5.37 M | 2.77 M | - | 7.56 M | 5.11 M | 2.55 M | - | 6.58 M | 4.45 M | 2.28 M | 904 K | 6.76 M | 4.4 M | 2.14 M | 1.22 M | 5.9 M | 3.82 M | 1.9 M | 1.22 M | 5.08 M | 3.39 M | 1.62 M | 1.21 M | 3.85 M | 2.55 M | 1.24 M | 3.2 M | 1.97 M | 962 K |
Accounts Payables |
10.5 M | 12.2 M | 14.5 M | 12.4 M | 15 M | - | 15.2 M | 12.7 M | 7.21 M | 15.2 M | 7.82 M | 6.82 M | 11.4 M | 7.82 M | 9.41 M | 4.84 M | 9.2 M | 9.41 M | 3.61 M | 6.24 M | 5.43 M | 3.61 M | 6.24 M | 3.13 M | 3.13 M | 3.07 M | 3.07 M | 6.81 M | 5.01 M | 5.22 M | 5.22 M | 5.44 M | 4.12 M | 10.2 M | 10.2 M | 11 M | 11.1 M | 6.96 M | 6.96 M | 8.96 M | 8.85 M | 4.8 M | 4.8 M | 8.82 M | 7.44 M | 6.56 M | 6.56 M | 8.96 M | 12.5 M | 8.08 M | 8.08 M | 6.37 M | 6.14 M | 5.52 M | 5.97 M | 4.52 M |
Accounts Receivables |
89.3 M | 84.1 M | 79.4 M | 76.9 M | 77.3 M | - | 70.1 M | 72 M | 73.5 M | 70.1 M | 76.7 M | 75.1 M | 77.5 M | 76.7 M | 79.7 M | 83.7 M | 76.9 M | 79.7 M | 84.4 M | 85.5 M | 87.5 M | 84.4 M | 85.5 M | 86.1 M | 86.1 M | 79.4 M | 79.4 M | 81.7 M | 81.6 M | 75.5 M | 75.5 M | 78.4 M | 81.8 M | 92.6 M | 92.6 M | 98.4 M | 100 M | 106 M | 106 M | 107 M | 112 M | 126 M | 126 M | 140 M | 139 M | 151 M | 151 M | 152 M | 153 M | 160 M | 160 M | 150 M | 149 M | 123 M | 113 M | 112 M |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 75 K | 58 K | 72 K | 75 K | 129 K | 153 K | 120 K | 129 K | 153 K | 161 K | 161 K | 154 K | 154 K | 147 K | 100 K | 252 K | 252 K | 353 K | 430 K | 662 K | 662 K | 649 K | 647 K | 665 K | 665 K | 745 K | 755 K | 928 K | 928 K | 996 K | 983 K | 3.91 M | 3.91 M | 3.86 M | 4.23 M | 3.19 M | 3.19 M | 2.79 M | 2.14 M | 1.94 M | 1.48 M | 1.39 M |
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company NextGen Healthcare, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Health information services sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Teladoc Health
TDOC
|
$ 6.26 | 0.24 % | $ 1.1 B | ||
|
10x Genomics
TXG
|
$ 65.6 | 4.71 % | $ 8.18 B | ||
|
Veeva Systems
VEEV
|
$ 264.84 | 1.3 % | $ 43.3 B | ||
|
Zhongchao
ZCMD
|
$ 0.85 | 0.29 % | $ 2.91 M | ||
|
Cerner Corporation
CERN
|
- | - | $ 27.9 B | ||
|
Change Healthcare
CHNG
|
- | - | $ 9.03 B | ||
|
Covetrus
CVET
|
- | - | $ 2.94 B | ||
|
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | ||
|
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | ||
|
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | ||
|
R1 RCM
RCM
|
- | - | $ 3.81 B | ||
|
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | ||
|
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | ||
|
American Well Corporation
AMWL
|
$ 13.34 | 2.69 % | $ 214 M | ||
|
Evolent Health
EVH
|
$ 4.22 | 1.41 % | $ 482 M | ||
|
GoodRx Holdings
GDRX
|
$ 3.52 | 1.15 % | $ 1.25 B | ||
|
Health Catalyst
HCAT
|
$ 1.7 | 0.59 % | $ 119 M | ||
|
HealthEquity
HQY
|
$ 93.36 | 0.24 % | $ 8.04 B | ||
|
HealthStream
HSTM
|
$ 28.72 | 1.78 % | $ 862 M | ||
|
So-Young International
SY
|
$ 2.65 | 0.18 % | $ 206 M | ||
|
iCAD
ICAD
|
- | - | $ 102 M | ||
|
Omnicell
OMCL
|
$ 33.88 | 0.32 % | $ 1.56 B | ||
|
OptimizeRx Corporation
OPRX
|
$ 7.6 | 1.74 % | $ 141 M | ||
|
Progyny
PGNY
|
$ 27.15 | 4.66 % | $ 2.31 B | ||
|
Phreesia
PHR
|
$ 10.22 | 0.76 % | $ 611 M | ||
|
Accolade
ACCD
|
- | 0.29 % | $ 206 M | ||
|
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | ||
|
Akerna Corp.
KERN
|
- | - | $ 161 M | ||
|
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | ||
|
Premier
PINC
|
- | - | $ 2.33 B | ||
|
Schrödinger
SDGR
|
$ 20.03 | 0.2 % | $ 1.47 B | ||
|
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | ||
|
SCWorx Corp.
WORX
|
- | - | $ 7.71 M |